Using Radiation Therapy to Prime and Propagate an Anti-tumor Immune Response Against Brain Tumors

被引:0
作者
Alejandro J. Onate
Paul A. Clark
Zachary S. Morris
机构
[1] University of Wisconsin-Madison School of Medicine and Public Health,Department of Human Oncology
[2] University of Wisconsin School of Medicine and Public Health,Carbone Cancer Center
来源
NeuroMolecular Medicine | 2022年 / 24卷
关键词
Brain tumors; Immunotherapy; Radiation; In situ vaccine; Melanoma;
D O I
暂无
中图分类号
学科分类号
摘要
Immunotherapies have demonstrated efficacy and survival benefits in some patients suffering from brain tumors; however, most do not respond and new approaches to enhance anti-tumor immunotherapeutic responses in the brain are needed. Radiotherapy remains a commonly used cancer treatment modality and can augment immunotherapeutic responses through multiple mechanisms. Recent preclinical studies may provide insight on how to optimally combine radiation and immunotherapies to maximize treatment efficacy. Unique aspects of the brain tumor microenvironment may play a critical role in limiting the successful application of immunotherapies in this location. Emerging studies suggest that such limits may be redressed through combination of immunotherapies with radiation therapy. In these settings, the latter may play a critical role in immunomodulating both tumor cells and the radiated brain tumor microenvironment. This review analyzes recent developments in combining radiation and immunotherapies to prime and better propagate anti-tumor immune response against brain tumors.
引用
收藏
页码:3 / 7
页数:4
相关论文
共 119 条
[1]  
Balogh A(2013)The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells Inflammation Research 62 201-212
[2]  
Persa E(2019)Prophylactic TLR9 stimulation reduces brain metastasis through microglia activation PLoS Biology 17 e2006859-880
[3]  
Bogdandi EN(2020)In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases Journal for Immunotherapy of Cancer 84 879-1851
[4]  
Benedek A(2012)Radiation therapy to convert the tumor into an in situ vaccine International Journal of Radiation Oncology Biology Physics 24 1845-186
[5]  
Hegyesi H(2018)Radiotherapy induces responses of lung cancer to CTLA-4 blockade Nature Medicine 30 181-1660.e17
[6]  
Safrany G(2020)Priming and propagating anti-tumor immunity: Focal hypofractionated radiation for in situ vaccination and systemic targeted radionuclide theranostics for immunomodulation of tumor microenvironments Seminars in Radiation Oncology 11 591139-134
[7]  
Benbenishty A(2020)Tumor-specific antibody, cetuximab, enhances the in situ vaccine effect of radiation in immunologically cold head and neck squamous cell carcinoma Frontiers in Immunology 181 1643-92
[8]  
Gadrich M(2020)Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells Cell 52 125-3941
[9]  
Cottarelli A(2018)Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers Seminars in Cancer Biology 1 71-834
[10]  
Lubart A(2003)Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: Mechanisms and implications Nonlinearity in Biology, Toxicology and Medicine 76 3929-4737